Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Buy
69
+49
+245% +$289 ﹤0.01% 2569
2026
Q1
$0 Buy
20
+14
+233% +$68 ﹤0.01% 2386
2025
Q4
$0 Hold
6
﹤0.01% 2373
2025
Q3
$0 Sell
6
-95
-94% -$741 ﹤0.01% 2398
2025
Q2
$1K Buy
101
+1
+1% +$10 ﹤0.01% 1976
2025
Q1
$1K Buy
100
+4
+4% +$52 ﹤0.01% 1963
2024
Q4
$1K Buy
96
+70
+269% +$984 ﹤0.01% 2026
2024
Q3
$0 Hold
26
﹤0.01% 2349
2024
Q2
$0 Buy
26
+1
+4% +$12 ﹤0.01% 2360
2024
Q1
$0 Buy
+25
New +$325 ﹤0.01% 2360

Other funds holding EOLS

Covestor's EOLS Position: Q2 2026 in Review

Covestor increased its Evolus (EOLS) stake by 245% in Q2 2026, buying an estimated $289 and bringing the position to 69 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2569.

Covestor first reported a position in EOLS in Q1 2024 and has held it in 10 quarters since. The position peaked at $1K in Q2 2025. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Covestor held 69 shares of Evolus worth $0 as of Q2 2026.
  • Covestor bought 49 Evolus shares in Q2 2026, an estimated $289.
  • Evolus made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2569 holding.
  • Covestor first reported a position in Evolus in Q1 2024 and has held it in 10 quarters since.
  • Covestor's Evolus position peaked at $1K in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.